August 8th 2025
New findings confirm TearCare's long-term effectiveness for dry eye disease, showing significant patient improvements with minimal treatments over 2 years.
Targeting dry eye in glaucoma patients
August 25th 2017A poor ocular surface is a common condition in glaucoma patients due to the incidence of dry eye, age, and use of benzalkonium chloride (BAK). Poor compliance with glaucoma therapy can result. Use of point-of-care testing can help identify patients with a poor ocular surface and drive treatment decisions. Treatment options, including surgical, are discussed.
Understanding the role of inflammation in dry eye
June 23rd 2017Optometry Times Editorial Advisory Board members Leslie E. O’Dell. OD, FAAO, and Scott Hauswirth, OD, FAAO, discuss their recent lecture on inflammation and the role it plays in ocular surface diseases at the American Optometric Association’s Optometry’s Meeting in Washington, DC.
6 challenges when changing from a group to private practice
March 10th 2017A little over 18 months ago, I decided to follow my passion and take a leap of faith changing my career. I went from a bustling MD/OD group practice to a private group OD practice and launched the Dry Eye Center of Pennsylvania (PA).
Complementary and alternative medicine help dry eye patients
September 21st 2016With the exponential increase of interest in dry eye or ocular surface disease (OSD) among physicians and the industry, we are fortunate to have access to exciting new diagnostic and imaging technology as well as new treatment options and therapeutics for some of our most frustrated patients.